$0.5248
-0.03-4.58%
At close: -
$0.5220
-0.00280-0.53%
After Hours: Feb 21, 6:42 PM EDT
Passage Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Passage Bio using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $-0.31 | $-0.23 | -34.8 % |
Q2 | 2024-08-08 | $-0.26 | $-0.31 | 16.1 % |
Q1 | 2024-05-14 | $-0.30 | $-0.36 | 16.7 % |
Q4 | 2024-03-04 | $-0.30 | $-0.40 | 25.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $0 | $3.33M | -100.0 % |
Passage Bio (PASG) is scheduled to report earnings on May 13, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
The Actual EPS was $-0.31, which missed the estimate of $-0.23.
The Actual Revenue was $0K, which missed the estimate of $3.3M.
Browse earnings estimates, EPS, and revenue on all stocks.